Litcius/Paper detail

Health-related quality of life with pembrolizumab monotherapy in patients with previously treated advanced microsatellite instability high/mismatch repair deficient endometrial cancer in the KEYNOTE-158 study

David M. O’Malley, Giovanni M. Bariani, Philippe A. Cassier, Aurélien Marabelle, Aaron R. Hansen, A. De Jesus Acosta, Wilson H. Miller, Tamar Safra, Antoîne Italiano, Linda Mileshkin, Mayur M. Amonkar, Yao Lu, Fan Jin, Kevin Norwood, Michele Maio

2022Gynecologic Oncology15 citationsDOIOpen Access PDF

Topics & Concepts

MedicineEndometrial cancerDiscontinuationPembrolizumabQuality of life (healthcare)Internal medicineMicrosatellite instabilityVisual analogue scalePopulationCancerOncologyClinical endpointPhysical therapyClinical trialAlleleGeneMicrosatelliteEnvironmental healthNursingImmunotherapyChemistryBiochemistryEndometrial and Cervical Cancer TreatmentsGenetic factors in colorectal cancerGynecological conditions and treatments